title: M-40403 Metaphore Pharmaceuticals.
abstract: Metaphore Pharmaceuticals Inc. is developing M-40403, a superoxide dismutase mimetic, for the potential treatment of pain, dermatological disease and inflammation. The company is also investigating the compound for its potential in the treatment for the side effects associated with chemotherapy and radiation therapy.
authors.affiliation: Neurological Section, SMDN-Center for Cardiovascular Medicine and Cerebrovascular Disease Prevention, Via Trento 41, I-67039-Sulmona (AQ), Italy. mariodinapoli@katamail.com
authors.forename: Mario
authors.initials: M
authors.lastname: Di Napoli
authors.forename: Francesca
authors.initials: F
authors.lastname: Papa
mesh_terms: D000700:Analgesics / Q000737:chemistry / Q000627:therapeutic use; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000737:chemistry / Q000627:therapeutic use; D015507:Drugs, Investigational / Q000737:chemistry / Q000627:therapeutic use*; D016166:Free Radical Scavengers / Q000737:chemistry / Q000627:therapeutic use; D006801:Humans; D008345:Manganese; D009942:Organometallic Compounds / Q000737:chemistry / Q000627:therapeutic use*; D013678:Technology, Pharmaceutical / Q000379:methods* / Q000639:trends
chemical_list: D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D015507:Drugs, Investigational; D016166:Free Radical Scavengers; D009942:Organometallic Compounds; C121876:imisopasem manganese; D008345:Manganese